We report that resveratrol (3,5,4'-trihydroxy-trans-stilbene), a phytoalexin found in grapes and other plant food, induced a breakdown of the mitochondrial transmembrane potential (∆Ψ m ) in T-acute lymphoblastic leukemia cells and swelling of isolated rat mitochondria. The breakdown of ∆Ψ m was accompanied by the production of reactive oxygen species (ROS), and preceded phosphatidylserine exposure and DNA fragmentation. Breakdown of ∆Ψ m was not caused by the activation of caspase-8 or Bid, as no significant cleavage of these proteins could be detected in the induction phase of resveratrol-induced apoptosis. Though loss of ∆Ψ m was not followed by cytochrome c translocation to the cytosol, the mitochondrial changes triggered significant activation of caspase-9, -2, -3, and -6. Inhibition of ∆Ψ m breakdown and of ROS generation by N-acetylcysteine, or by overexpression of Bcl-2 protein, prevented apoptosis induction by resveratrol. The Bcl-2 expression status of tumor cells should therefore be considered relevant for potential clinical application of resveratrol as anticancer agent.
esveratrol, a polyphenolic compound present in grapes and in red wine, has been found to inhibit cellular events that increase the risk of carcinogenesis, a finding that has initiated numerous studies on its molecular mechanisms. These studies revealed antioxidant activities such as the inhibition of free radical formation following TPA stimulation (1) and of peroxidation of lipids in microsomes and of plasma LDL (2) . Further mechanisms of action comprise modulation of lipoprotein metabolism and inhibition of platelet aggregation and coagulation (3) . Its chemopreventive properties have been demonstrated in vitro, where resveratrol lowers the mutagenic responses induced in salmonella by the aryl hydrocarbon dimethylbenz [a] anthracene treatment and induces quinone reductase activity (an enzyme capable of detoxifying carcinogens) (4) . Moreover, it strongly inhibits P450-1A1 activity (an enzyme that transforms environmental toxins and procarcinogens into ultimate carcinogens), and it prevents dioxin toxicity by antagonistic activity on the aryl hydrocarbon receptor (5).
More recently, its antioxidant and chemopreventive effects have been demonstrated in vivo by showing that it prevents the development of preneoplastic lesions in carcinogen-treated mouse mammary glands and inhibits tumorigenesis in a mouse skin cancer model (6) . These results may be explained by its growth-inhibitory effects on tumor cell lines; by its capacity to directly induce apoptosis in various human tumor models, including promyelocytic leukemia (7), prostate cancer (8) , and breast cancer (9, 10) ; and by its tumor specificity, because it does not affect human peripheral blood lymphocytes from healthy donors (9) . The growth-inhibitory effect of resveratrol might result from its influence on the expression levels or phosphorylation status of cell cycle regulators such as cyclin E, cyclin A, cdc2, and Rb, thereby arresting cell division cycle at S/G2 phase transition (11) Furthermore, the direct inhibition of ribonucleotide reductase activity by resveratrol might also contribute to its growth-inhibitory activities (12) . Initiation of the apoptotic program might occur directly via caspase-2 and caspase-6 activation (13), through p53 and p21 up-regulation (14) , or as a result of direct DNA cleavage by resveratrol (15) . The proposed activation of the Fas/FasL pathway (9) following Fas and FasL up-regulation and suicidal activation of caspase-8 and caspase-3 is controversial, with the results from our and other groups arguing against a role of this death program in cell death triggered by resveratrol (13, 16) . Additionally, blockage of survival signals via inhibition of PKC activity (17) , of ERK1 and ERK2 phosphorylation, and of nuclear translocation (18) might exert an initiation signal for apoptosis. These data point to highly divergent signal pathways activated by resveratrol in different tumor models and/or to a pleiotropy in mechanisms leading to prevention of carcinogenesis or to induction of apoptosis by resveratrol. The present study was undertaken to identify the contribution of mitochondrial components to the induction of apoptosis in tumor cells by resveratrol, by using the T-acute lymphoblastic leukemia (T-ALL) cell line CCRF-CEM as a model and to assess possible modulatory effects of Bcl-2 family members as important guardians of mitochondrial functions in this response.
MATERIALS AND METHODS

Reagents and antibodies
The following reagents and antibodies were used in this study: resveratrol (Sigma, Vienna, Austria); N-acetylcysteine (Sigma); cyclosporin A (Calbiochem, San Diego, CA); antihuman Bcl-2 (Dako, Vienna, Austria); antihuman Bax (Santa Cruz, Santa Cruz, CA); antihuman caspase-2, -3, -6, and -9 (all from Pharmingen, San Diego, CA); antihuman caspase-8 (Upstate Biotechnologies, Lake Placid, NY); antihuman Bid (Pharmingen); antihuman cytochrome c (Pharmingen); antihuman cytochrome c oxidase (Molecular Probes, Leiden, Netherlands); and antihuman Fas (clone CH11, Immunotech, Marseille, France). The polyclonal rabbit antihuman AIF antibody was generated and characterized as described previously (19) .
Cell lines and culture conditions
The T-ALL cell line C7H2-2A10 was used, which is a subclone of the CEM-C7H2, a glucocorticoid-sensitive subline of CCRF-CEM. CEM-C7H2-9C3 and -9F3 are derivatives of the C7H2-2A10 cell line that are stably transfected with human bcl-2 cDNA under the control of the tetracycline-sensitive transcriptional repressor ('tet-off' system) (20) . The Jurkat subclone with a knock-out mutation in the caspase-8 gene was kindly provided by Dr. Peter Juo, Department of Cell Biology, Harvard Medical School (21) . All cell lines were cultured in RPMI-1640 media (Seromed, Berlin, Germany) supplemented with 10% heat-inactivated fetal calf serum (FCS, Biological Inc., Beth Haemek, Israel), 2 mmol/l L-glutamine (Seromed, Germany), and 100 µg/ml gentamycin (GIBCO, Grand Islands, NY) at 37°C in a humidified atmosphere containing 5 % CO 2 .
Immunoblotting
Cells (5 × 10 6 ) were resuspended in 100 µl lysis buffer (50 mmol/l Tris/HCl pH 7.5, 150 mmol/l NaCl, 2 mmol/l EDTA, 1 mmol/l EGTA supplemented with 25 µg/ml leupeptin, 25 µg/ml aprotinin, and 1% Triton X-100) and were three times frozen and thawed in liquid nitrogen. The samples were cleared by centrifugation (14 000 x g, 30 min, 4°) and corrected for protein concentrations. SDS/PAGE was performed under reducing conditions in Tris/glycine-buffered gels (Novex, San Diego, CA). Proteins were transferred onto polyvinylidene difluoride membranes (Millipore, Bedford, MA) by tank blotting (220 mA, 70 min, 4°C). The membranes were blocked for 1 h in Tris-buffered saline containing 0.05% Tween-20 and 5% nonfat dry milk, followed by incubation with the primary antibody (Ab) at a dilution of 1:1000. Horseradish peroxidase (HRP)-conjugated Ab (Dako, Copenhagen, Denmark) were used as secondary Ab (dilution 1:1000). HRP-labeled antibodies were detected in a luminol-based chemiluminescent reaction (Amersham Life Sciences, Buckinghamshire, U.K.).
Immunofluorescence
Cells were washed twice with PBS, and 4 × 10 4 cells were centrifuged onto glass slides (100 g, room temperature, 4 min), dried overnight, fixed, and permeabilized for 15 min at room temperature with PBS complemented with 4% paraformaldehyde and 0.05% saponin and washed with 0.03% saponin/PBS. Thereafter, cells were blocked with blocking solution (1% bovine serum albumin, 1% FCS, 0.1% Tween 20 in PBS) for 30 min at room temperature, washed twice in PBS, and incubated with 1 µg of the primary antibody in 100 µl blocking solution. The incubation with an isotype-matched control antibody served as negative control. Again, cells were washed twice in PBS, and the secondary antibody (dilution 1:10 in blocking solution was added for 1 h at room temperature. Finally cells were washed and coated with 1 drop of mounting medium and a coverglass. The analysis of staining intensity and pattern was done by using an Olympus IX-70 microscope equipped for fluorescence observation (Olympus Austria, Vienna). The digital pictures were taken by using the Kappa DX30 CCD camera (Kappa optoelectronics, Gleichen, Germany).
Subcellular fractionation of mitochondria
Cells were washed twice with PBS, and the pellet was suspended in 0.4 ml of homogenizing buffer (250 mmol/l sucrose, 3 mmol/l HEPES-KOH pH 7.38, 1 mmol/l EGTA, 0.5 µg/ml BSA). The cell pellet was homogenized by using a Potter-Elvehjem Teflon homogenizer by 40 gentle up-and-down strokes. Nuclei and intact cells were removed by centrifugation (600 g, 10 min), supernatants were collected and centrifuged again (10,000 g, 10 min). The supernatant (cytosolic fraction) and the pellet (mitochondrial fraction) were separated and the mitochondria-containing pellet resuspended in resuspension buffer (300 mmol/l sucrose, 3 mmol/l HEPES-KOH pH 7.38, 1 mmol/l EGTA, 0.5 µg/ml BSA, 10 µmol/l aprotinin, 10 µmol/l leupeptin). The mitochondrial suspension was subjected to ultrasonic treatment (5 min), and prepared for immunoblotting.
Detection of phosphatidylserine exposure on apoptotic cells
Staining of cells with the combination of annexinV/FITC and propidium iodide was performed according to manufacturer's instructions for detection of early (annexinV/FITC + /PI -) and late (annexinV/FITC + /PI + ) apoptotic cells; both subpopulations together were considered to represent the total fraction of apoptotic cells (22) . Briefly, 2.5 × 10 5 cells were incubated with saturating concentrations of annexinV/FITC (Alexis, Läufelfingen, Switzerland) and propidium iodide (Sigma) for 15-30 min at room temperature and immediately analyzed by flow cytometry.
Detection of DNA strand breaks
DNA single-strand breaks ("nicks") occurring in the early phase of resveratrol-induced apoptosis were analyzed by using the In Situ Cell Death Detection kit (Roche, Mannheim, Germany) according the manufacturer's instructions. Single-strand breaks could be identified by labeling free 3'-OH termini with fluorescein-labeled nucleotides in a reaction catalyzed by terminal deoxynucleotidyl transferase (TdT). Incorporated fluorescein was analyzed under light microscope and by flow cytometry. For positive control, cells were fixed, permeabilized, and incubated with 100 µg/ml DNAse I (Roche Diagnostics, Vienna, Austria).
For detection of double-strand breaks yielding low molecular weight DNA fragments, the cellular DNA content was stained with propidium iodide (Sigma) solution (Triton X-100 0.1%, propidium iodide 50 µg/ml, sodium citrate 0.1 %). Cells with cleaved DNA and hence lower stainability ('sub-G1' peak) were quantified by flow cytometry.
Assessment of the mitochondrial transmembrane potential (∆Ψ m )
The breakdown of the mitochondrial transmembrane potential (∆Ψ m ) was followed by staining cells with the dual-emission potential-sensitive probe 5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolylcarbocyanine iodide (10 µmol/l) (JC-1, Molecular Probes, Leiden, Netherlands) for 20 min at RT. This fluorochrome has been demonstrated to be a reliable probe for assessing ∆Ψ m changes during apoptosis (23) . Immediately after washing with PBS, the fluorescence signal intensity of FL-2 (representing cells with high mitochondrial transmembrane potential) and of FL-1 (cells with low mitochonrial transmembrane potential) were analyzed by flow cytometry. To confirm the results obtained by JC-1, experiments were performed in which cells were stained with the potential-sensitive dyes Mitotracker Red CMXRos (2 µg/ml, Molecular Probes) or 3,3'-dihexyloxacarbocyanine iodide (40 nmol/l, DiOC6(3), Molecular Probes) and analyzed by flow cytometry.
Isolation of rat liver mitochondria and measurement of PTPC opening
Rat liver mitochondria from Wistar albino rats, prepared by standard differential centrifugation as previously described (24), were suspended in swelling buffer (0.2 mol/l sucrose, 10 mmol/l Tris-MOPS, pH 7.4, 5 mmol/l succinate-Tris, 1 mmol/l P i , 2 µmol/l rotenone, and 10 µmol/l EGTA-Tris) at a protein concentration of 0.5 mg/ml. Osmotic swelling of mitochondria was monitored as the change of 90° light scattering at 545 nm by using a Hitachi F-4500 fluorescence spectrophotometer.
Detection of reactive oxygen species
Cells were labeled with hydroethidine (Molecular Probes, 2 µmol/l) in cell culture medium and incubated for 15 min at 37°C in a humidified atmosphere at 5% CO 2 . Immediately after washing with PBS, the fluorescence intensity was measured by flow cytometry. The generation of ROS was monitored by the conversion of hydroethidine to ethidium, detected as an increase in the emission of red fluorescent light (FL-2 channel).
Detection of caspase-2, -3, and -6 activity
The enzymatic activity of caspase-2, -3, and -6 was determined by using chromogenic substrates (all products from ALEXIS, Läufelfingen, Switzerland) containing the specific cleavage sites, namely VDVAD for caspase-2, DEVD for caspase-3 and VEID for caspase-6, linked to pnitroaniline (pNA). Cell lysate (50 µg) of untreated cells or cells treated with resveratrol for 8 h and 24 h were mixed with the chromogenic substrate and the absorption at 405 nm (given as optical density, OD) was taken as specific caspase activity.
RESULTS
Resveratrol-induced apoptosis is inhibited by Bcl-2
Induction of apoptosis by multiple classes of chemotherapeutic agents is inhibited in vitro by Bcl-2, and this effect is proportional to the level of Bcl-2 expression (25, 26) . To study the role of Bcl-2 in resveratrol-induced apoptosis, we used subclones of the CEM-C7H2 T-ALL cell line, which stably overexpressed Bcl-2 (20) . After resveratrol treatment of the vector control cell line, apoptosis was induced in a time- (Fig. 1 ) and dose-dependent manner (13) . Bcl-2 overexpression protected cells from resveratrol-induced apoptosis ( Fig. 1) , even over the extended incubation period of 72 h (data not shown).
Resveratrol induces a breakdown of the mitochondrial transmembrane potential
The breakdown of mitochondrial transmembrane potential has been described in the execution phase of the apoptotic cascade following a broad spectrum of stimuli-like dexamethasone (27, 28) , ceramide (29) , or Fas-triggering (30) . Because Bcl-2 has been shown to localize to mitochondria (31) , to stabilize the mitochondrial membrane barrier function, and to inhibit the opening of the permeability transition pore complex, thereby suppressing the release of proapoptotic effector molecules, we set out to examine whether resveratrol caused a breakdown of ∆Ψ m and whether this is blocked by Bcl-2. We observed a very rapid initial breakdown of ∆Ψ m already 5 min after addition of resveratrol (100 µmol/l), which was transient ( Fig. 2A ) and a second, persisting decrease of ∆Ψ m , which started after 4 h and continued to decrease during the time course of observation (Fig. 2B ). In the CEM-C7H2 subclone with high Bcl-2 expression levels, no immediate changes in ∆Ψ m could be observed ( Fig. 2A) and the second increase in the percentage of cells with a loss of ∆Ψ m was significantly reduced (Fig. 2B) . Essentially, the same results were obtained by using a different Bcl-2 overexpressing subclone (data not shown).
Resveratrol has a direct effect on the permeability transition pore complex of mitochondria
It has been reported that the reduction of ∆Ψ m is caused by the opening of the permeability transition pore complex in the inner and/or outer mitochondrial membrane, which can be detected directly by influx of water and sucrose in sucrose-containing media, leading to largeamplitude swelling of isolated mitochondria (32). Because we observed immediate changes in ∆Ψ m following resveratrol treatment of intact cells ( Fig. 2A) , we wondered whether this drug had a direct effect on the permeability of the mitochondrial membranes and whether this can be prevented by cyclosporin A (CsA), a substance that specifically blocks the opening of the permeability transition pore complex (33) . We isolated mitochondria from rat liver and monitored the swelling of mitochondria as change of the 90° light-scattering profile of mitochondria at 545 nm (see Material and Methods). Ca 2+ (20 µmol/l) was added as positive control. As shown in Figure 3 , the addition of resveratrol to the mitochondrial suspension induced the swelling of increasing numbers of mitochondria, which was prevented by CsA.
Reactive oxygen species (ROS) are produced following resveratrol stimulation of C7H2 cells
Reactive oxygen species (ROS) are involved both in the induction and in the decision/effector phases of apoptosis (reviewed in (34)). During the cell death program, mitochondrial electron transport is uncoupled from ATP synthesis, thus causing the generation of superoxide anions. Production of ROS can contribute to mitochondrial damage, which may facilitate the further release of ROS into the cytoplasma. Because we observed the breakdown of the mitochondrial transmembrane potential by resveratrol treatment, we wanted to find out whether an increase in ROS could also be observed in cells treated with resveratrol. We detected intracellular ROS production following resveratrol treatment by staining cells with the ROS-sensitive fluorescent dye hydroethidine (HE). As shown in Figure 4A , an increase in red fluorescence intensity could already be observed 30 min after the addition of resveratrol and steadily increased over the time frame of observation. According to the inhibitory effect of Bcl-2 expression on the breakdown of ∆Ψ m , following resveratrol addition, Bcl-2 significantly reduced resveratrol-induced production of ROS (Fig. 4A) .
ROS scavenge protects CEM-C7H2 cells from resveratrol-induced apoptosis
To elucidate whether the increase in ROS is responsible for the loss of ∆Ψ m as well as for resveratrol-induced apoptosis, we pretreated cells for 1 h with the radical scavenger Nacetylcysteine (N-AC, 5 mmol/l) before addition of resveratrol. The pretreatment significantly lowered the generation of ROS by resveratrol as well as the breakdown of ∆Ψ m (Fig. 4B) , suggesting that ROS may not only develop downstream from changes in the mitochondrial transmembrane potential, but may also act upstream and contribute to the loss of ∆Ψ m . The levels of ROS were reduced to those observed in Bcl-2 overexpressing cells (see Fig. 4A ), which is in good concordance with the antiapoptotic function of Bcl-2 via an antioxidant pathway. As expected, pretreatment with N-AC also protected CEM-C7H2 cells from DNA fragmentation induced by resveratrol (Fig. 4B) .
Resveratrol-induced apoptosis does not involve subcellular translocation of cytochrome c
To detect whether cytochrome c release from mitochondria occurs in the course of resveratrolinduced apoptosis, we first examined the subcellular distribution of cytochrome c by immunofluorescence staining. Cytochrome c staining yielded a particulate pattern, which reflected the mitochondrial distribution of cytochrome c (Fig. 5A ) and which colocalized with the respiratory chain enzyme cytochrome c oxidase (Fig. 5B) . Despite the clear effect of resveratrol on the mitochondrial permeability transition pore complex and transmembrane potential, no diffuse staining pattern of cytochrome c, which would reflect a translocation to the cytosol could be observed at the time points analyzed (1 h, 4 h, 8 h, 16 h, and 24 h, Fig. 5 A-D, and data not shown); in contrast, the particulate staining signal of cytochrome c in the mitochondrial structures became even more intense (Fig. 5C ) and colocalization with cytochrome c oxidase remained unchanged. Essentially the same results were obtained even when twice as high a concentration of resveratrol (200 µmol/l) was used (data not shown). The translocation of cytochrome c to the cytosolic compartment could be seen using Fas stimulation of C7H2 cells as a positive control (Fig. 5D ). To confirm these results, we prepared subcellular fractions containing either mitochondria or cytosol and detected cytochrome c by immunoblotting. Despite the comparable extent of apoptosis induction following stimulation by resveratrol or anti-Fas mAb (Fig. 5E ), no translocation of cytochrome c to the cytosolic compartment could be observed after stimulation with resveratrol, while activation of the Fas pathway led to the accumulation of cytochrome c in the cytosol (Fig. 5E ).
Caspase-8 activation and Bid cleavage
Caspase-8-induced cleavage of Bid, a Bcl-2 family member, leading to a subsequent breakdown of ∆Ψ m , has been described in death receptor-induced apoptosis. This specific mitochondriadependent apoptotic pathway is thought to represent an amplification mechanism for efficient caspase-3 activation following death receptor stimulation in type II cell types (35) . In a previous study, we demonstrated that processing of caspase-8 became detectable only 24 h after resveratrol addition (13) . We now raised the question whether activation of Bid is involved in resveratrol-induced apoptosis of CEM-C7H2 cells and analyzed Bid by immunoblotting using an antibody that detects both intact and cleaved Bid protein. The quantity of Bid cleavage products remained under the detection limit of the assay, whereas a significant decrease of the unprocessed protein could be seen after stimulation of cells with CH11 mab as a positive control (Fig. 6a) . These results argue against the contribution of activated caspase-8 and Bid to the early effects of resveratrol on mitochondria. Furthermore, Jurkat cells with a knock-out mutation in the caspase-8 gene as well as C7H2 cells stably expressing the cowpox serpin crmA (an inhibitor of Fas and TNF-α mediated apoptosis at the level of caspase-8) were sensitive to resveratrolinduced apoptosis, whereas they did not undergo apoptosis following Fas activation (13) . These results argue against the activation of the type II death receptor pathway as the main target in resveratrol-induced apoptosis in the T-ALL cell lines examined.
Resveratrol leads to cytochrome c-independent activation of caspase-9
Caspase-9, the central executioner protease, becomes activated in a complex with cytochrome c, dATP, and APAF-1 (the so-called apoptosome) (36) . Because we could not detect cytochrome c translocation to the cytoplasm following resveratrol treatment of CEM-C7H2 cells, which is thought to represent a prerequisite for the formation of the apoptosome and thus for efficient caspase-9 activation (36), we wondered whether caspase-9 is activated by resveratrol and whether Bcl-2 can prevent caspase-9 activation. We therefore prepared cell lysates from untreated cells and from cells treated with resveratrol for different times (4 h, 8 h, and 24 h), and analyzed them for caspase-9 in its proform (47 kDa) and its processed form (37 kDa). Fastriggered activation of caspase-9 following the addition of the agonistic antibody CH-11 (250 ng/ml, 8 h) was measured as positive control. In CEM-C7H2-VC cells, caspase-9 in its activated form became already detectable after 8 h of resveratrol treatment (Fig. 6B) . The extent of caspase-9 processing by resveratrol (24 h) or by Fas activation (8 h) was comparable with the capability of each stimulus to induce apoptosis as detected by the AnnexinV/FITC/propidium iodide analysis (Fig. 5E ). In the Bcl-2 overexpressing subclone, no signal for activated caspase-9 could be detected following resveratrol treatment (Fig. 6B) .
Activation of caspases-2, -3 and -6 by resveratrol is inhibited by Bcl-2
In a previous study we showed that caspases-2, -3, and -6 are activated by resveratrol in a timedependent manner (13) . To clarify whether the activation of caspases by resveratrol is also under the control of Bcl-2-dependent processes and therefore occurs downstream of mitochondrial signaling, we analyzed the processing of caspase-2, -3, and -6 by assessing cell extracts for hydrolyzing activity of the caspase-specific peptides VDVAD-pNA (for caspase-2), DEVD-pNA (for caspase-3), and VEID-pNA (for caspase-6), respectively. Resveratrol initiated the processing of substrates in the C7H2 vector control cell line but not in the Bcl-2 overexpressing subclone (Fig. 7) . Identical results were observed by detecting the pro-and active forms of caspase-2, -3, and -6 by using immunoblotting as a read-out system (Fig. 7) .
Induction of DNA strand breaks by resveratrol occurs downstream of mitochondrial signaling
Resveratrol has been reported to be capable of binding to DNA and of inducing DNA damage in a Cu 2+ -dependent way (15) . To elucidate whether the changes of mitochondrial transmembrane potential following resveratrol treatment are later effects induced by DNA cleavage observed ex vivo, we determined DNA strand breaks in C7H2 cells after resveratrol incubation. DNAse treatment as a positive control yielded DNA strand breaks in a time-dependent manner in C7H2 cells (data not shown). Significant induction of DNA strand breaks by resveratrol started after 8 h and therefore followed ∆Ψ m changes and ROS production; this excludes the induction of DNA damage as the primary effect of resveratrol in these cells (Fig. 8A) . Resveratrol-induced increase in DNA strand breaks was significantly blocked in the Bcl-2 overexpressing subclone (Fig. 8B) .
Resveratrol does not induce the translocation of apoptosis-inducing factor from mitochondria to the nucleus
Apoptosis inducing factor (AIF) is a novel apoptotic effector protein that induces chromatin condensation and DNA fragmentation when added to purified nuclei in vitro. AIF is restricted to mitochondria and translocates to the nucleus after apoptosis induction by staurosporin, etoposide, dexamethasone, or ceramide in a Bcl-2-regulated process (19, 37) . Because we measured mitochondrial changes in C7H2-VC cells but did not observe the translocation of cytochrome c from mitochondria to the cytosol following resveratrol treatment, we wondered whether the loss of mitochondrial transmembrane potential would lead to the release of AIF from the mitochondrial intermembrane space, thus representing the link between mitochondria and nucleus in resveratrol-induced apoptosis. We prepared nuclear and mitochondrial fractions of C7H2-VC cells and the Bcl-2 overexpressing clones and detected AIF by immunoblotting. Stimulation of cells by the anti-Fas agonistic antibody CH11 was included as positive control. As shown in Figure 9 , the signal of AIF in the mitochondrial fractions did not decrease following resveratrol treatment of cells, suggesting that this pathway of caspase-independent activation of nucleases is not involved significantly in resveratrol-induced apoptosis.
DISCUSSION
Our present work provides evidence that the modulation of ∆Ψ m and the generation of ROS constitute early events of the resveratrol-induced apoptotic pathway, which are not preceded by direct activation of caspase-8 or Bid and are not accompanied by subcellular translocation of cytochrome c. Despite the lack of cytochrome c release from mitochondria, caspases-2, -3, -6, and -9 are activated in resveratrol-induced apoptosis and they function downstream of ∆Ψ m breakdown and ROS generation. Moreover, the pro-apoptotic effects of resveratrol cannot be attributed to a direct induction of DNA damage, which was observed ex vivo (15) . Generation of ROS and loss of ∆Ψ m are both inhibited by overexpression of Bcl-2, which also blocked all further downstream effects, including phosphatidylserine exposure, caspase activation, and DNA damage.
The loss of mitochondrial transmembrane potential as an important event of apoptotic pathways preceding caspase activation and nuclear changes is a phenomenon constantly observed in different types of cell death. In our study, we observed a decrease in the mitochondrial transmembrane potential following addition of resveratrol ( Fig. 2A) , which was diminished in Bcl-2 overexpressing cells. A protective effect of Bcl-2 against ∆Ψ m breakdown has been observed following treatment of cells with glucocorticoid, ceramide (29) , TNF (38) , Fas (35) , and in p53-induced apoptosis (39) . Bcl-2-specific maintenance of ∆Ψ m might result from its capacity to prevent the physical interaction of the pro-apoptotic protein Bax with the adenine nucleotide translocator (ANT) protein , which, when added together with Bax to artificial lipid bilayers, have been shown to form a channel (40) . Pore formation by ANT and Bax could result in transient breakdown of ∆Ψ m , and by osmotic matrix swelling, permeabilization of the outer mitochondrial membrane may occur (41) . We observed both a rapid transient ∆Ψ m breakdown ( Fig. 2A) and immediate osmotic swelling following application of resveratrol to intact cells ( Fig. 2A) and to isolated mitochondria, respectively, (Fig. 3) . These data favor the idea that resveratrol interacts directly with mitochondrial membrane components. This hypothesis is substantiated by the results of Zheng et al., demonstrating that resveratrol inhibits F 0 F 1 ATPase activity by targeting the F1 region, which is located at the inner membrane of mitochondria (42) . Because Bcl-2 inhibits the early transient loss of ∆Ψ m , the direct interaction of resveratrol with components of the inner mitochondrial membrane might be blocked by the presence of Bcl-2.
The hyperproduction of ROS following the opening of the permeability transition pore complex has been observed in programmed cell death in various cell models (29) . We found that resveratrol, besides its effect on mitochondrial potential, leads to an increase in ROS production in CEM-C7H2 cells (Fig. 4A) . Generation of ROS by the antioxidant resveratrol seems paradoxical, in particular because it has been shown by Zini et al (43) that resveratrol can decrease the activity of complex III of the mitochondrial respiratory chain, the site where ROS are generated. Based on their results, these authors proposed a model in which resveratrol-by decreasing the activity of complex III-cannot only oppose the production of ROS but also scavenge them. At this stage, we cannot rule out that the antioxidant activity of resveratrol diminishes the increase in ROS levels generated by its action on mitochondria. Such opposing effects of either increase or decrease of ROS by resveratrol, depending on its concentration, have been observed in blood platelets (44) . Because we observed an early transient loss of ∆Ψ m , which was followed by both a time-dependent increase in ROS as well as a second lasting decrease of ∆Ψ m , we propose a model where transient ∆Ψ m breakdown causes local generation of ROS, which then, in a positive feedback loop, further reduces ∆Ψ m . This is additionally substantiated by the observation that pretreatment of cells with N-AC, a scavenger of radicals, diminished not only resveratrol-induced ROS generation but also blocked the loss of ∆Ψ m (Fig.  4B) . The generation of ROS by resveratrol in CEM-C7H2 cells was also blocked by overexpression of Bcl-2. Besides the above-mentioned direct interaction of Bcl-2 with mitochondrial components of the permeability transition pore complex, its interference with oxidative cell death has been shown to act on at least two additional levels: inhibition of free radical production and detoxification of ROS (45) . We conclude from our results that Bcl-2, which inhibited the early transient and the second lasting loss of ∆Ψ m , might operate in two ways: first, by directly antagonizing the early loss of ∆Ψ m and ROS production and second, by preventing the emergence of the feedback loop.
It has been shown recently that cytochrome c release can also occur independently of ∆Ψ m breakdown (46) , and furthermore it is a very rapid and kinetically constant process. However, its onset varies considerably between different stimuli or between different cells (47) . Although cytochrome c, representing an important component of the respiratory chain, is essential for ATP production, it is unclear at present how mitochondria can maintain ∆Ψ m after the translocation of cytochrome c to the cytosol. Green and his team hypothesized, based on their study, that either some cytochrome c remains in the mitochondria or that it reenters the intermembrane space and participates in the electron-transport (47). We could not detect cytochrome c in the cytosolic compartment of C7H2 cells at any of the time points analyzed between 1 h and 24 h after the addition of resveratrol (Fig. 5 and data not shown) . This finding might be explained by the formation of a pore that is too small in size to allow the efflux of cytochrome c. However, because we did not use cells stably expressing GFP-labeled cytochrome c, we cannot exclude the possibility that resveratrol triggers a very rapid release of cytochrome c, which then quickly reenters mitochondria.
Scientists working in the field of apoptosis agree that cytochrome c, following its release from mitochondria, binds to APAF-1 and then activates caspase-9. In addition, Slee and co-workers (48) concluded from depletion studies targeting caspase-9, that caspase-9 activity is indispensable for the cytochrome c-inducible activation of all other downstream caspases; that is, caspase-2, -3, -6, -7, -8, and -10. Our data now provide evidence that the activation of caspase-9, -2, -3, and -6 by resveratrol does not depend on cytosolic cytochrome c, at least not at cytochrome c concentrations, which are detectable by the methods applied in this study, that it follows the breakdown of ∆Ψ m and that it is regulated by Bcl-2. Cytochrome c-independent caspase-9 activation by cytotoxic endoribonuclease treatment has been reported recently (49) . Disruption of ∆Ψ m , ROS production and activation caspase-3-like proteases in the absence of Bid activation and of cytochrome c release has also been described in p53-induced apoptosis in HeLa cells (39) . Furthermore, in yeast, ectopic expression of Bax was found to hyperpolarize mitochondrial membranes, to increase the production of ROS, and-despite mitochondrial changes-to induce cell death without detectable release of cytochrome c (50) . From these reports and from our study, it can be concluded that either high cytoplasmatic concentration of cytochrome c are not indispensable for efficient activation of caspase-9 (49) or that caspase-9 activation in the apoptosome might be initiated via an as yet unidentified alternative component. Alternatively, given the presence of caspase-9 (51, 52), cytochrome c, and ATP in mitochondria, the formation of the apoptosome within the intermembrane space following influx of APAF-1 cannot be excluded and has yet to be analyzed.
It has been shown recently that resveratrol-induced apoptosis occurs only in cells expressing wild-type p53, but not in p53-deficient cells (53) . The CEM-C7H2 cell line used in this study is heterozygous for the mutant p53 alleles R175H and R248Q, which disrupt the tertiary structure of p53 and result in absent transactivation of known endogenous p53-responsive genes such as p21/WAF, mdm-2, and bax (54) . However, functions of p53, independent of its transcription factor activity, may be conserved, and this cell line has been shown to express all relevant signaling molecules for p53-mediated apoptosis (54) . From our present study and in agreement with the report of Li et al (39) , we conclude that the signal cascades to cell death activated by resveratrol and by p53 seem to share many similarities. Adenoviral-mediated expression of p53 in HeLa cells has been reported to lead to production of ROS, to changes in mitochondrial transmembrane potential and to cytochrome c-independent activation of caspase-3 like caspases, with all these cellular events blocked by overexpression of Bcl-2 (39). To answer the question whether resveratrol might be used for treatment of tumors with a loss-of-function mutation in the p53 gene and whether its therapeutic application can replace sophisticated gene transfer of wildtype p53, a broader spectrum of tumor cell models needs to be analyzed.
In conclusion, elevated Bcl-2 expression of tumor cells might represent an important stumbling block to the efficacy of resveratrol when applied as a single agent in tumor therapy. Combined strategies with Bcl-2-antagonizing cytotoxic agents should therefore be evaluated in future studies. Bcl-2 cells (clone 9C3)-untreated or treated with resveratrol (100 µmol/l) for the indicated time points, were prepared and subjected to immunoblotting, and Bid (26 kDa) was detected. Fas stimulation by CH11 mab (250 ng/ml, 8 h) was used as positive control. Representative results from three independent experiments are shown. Tubulin was detected as internal control. (B) Caspase-9 is activated by resveratrol, which is blocked by Bcl-2. Cell extracts from C7H2-VC and from C7H2-Bcl-2 cells (clone 9C3)-untreated or treated with resveratrol (100 µmol/l) for the indicated time pointswere prepared, and the proform (47 kDa) and activated form (37 kDa) of caspase-9 were detected by immunoblotting. Fas stimulation by CH11 mab (250 ng/ml, 8 h) was used as positive control. Representative results from three independent experiments are shown. Identical results were obtained by using the Bcl-2 overexpressing clone 9F3 (data not shown). -2, -3, and -6 . Cell extracts from C7H2-VC and from C7H2-Bcl-2 cells (clone 9C3)-untreated or treated with resveratrol (100 µmol/l) for the indicated time pointswere prepared and analyzed for their ability to hydrolyze the peptide substrates (VDVAD for caspase-2, DEVD for caspase-3, and VEID for caspase-6). Bars represent absorption at 405 nm given in arbitrary units. In parallel, cell extracts were subjected to immunoblotting for detection of proform and processed form of caspases. Representative results from three independent experiments are shown. 
